Target Discovery Pharmacovigilance: Tool Calling and Plugins

Target discovery data is typically highly structured. It originates from public databases (e.g., ChEMBL, DrugBank, PubChem), patent literature

Data Characteristics in this Category

Target discovery data is typically highly structured. It originates from public databases (e.g., ChEMBL, DrugBank, PubChem), patent literature, clinical trial reports, and scientific papers. Data update frequencies vary; public databases might update quarterly or semi-annually, while research papers and patents are continuously published. Data documents exist in XML, JSON, CSV, or proprietary database formats. They contain information such as compound structures, target affinities, pharmacodynamic data, mechanisms of action, and disease associations. Fields often include SMILES strings, InChIKeys, protein sequence IDs (e.g., UniProt ID), IC50/EC50 values and their units (e.g., nM, µM), and coded drug adverse event data (e.g., MedDRA codes). Some data may exist as unstructured text within scientific literature abstracts.

Constraints Imposed by These Characteristics on "Tool Calling and Plugins"

The diversity and update frequency of target discovery data impose specific requirements on tool calling and plugins. Structured data requires precise field mapping and data type conversion to ensure tools parse and process it correctly. For example, recognizing SMILES strings and protein sequence IDs requires specific parsing capabilities from the tools. Unstructured text requires integration with Natural Language Processing (NLP) tools for entity extraction and relationship identification. Due to numerous data sources and varying update rhythms, tools must consider data freshness during calls and support multi-source data integration. For numerical data like target affinity, tools need to handle unit conversions and dimensional harmonization. Furthermore, the standardized coding of drug adverse event data (MedDRA) requires tools to perform normalized queries and matching, preventing information omission or misreporting due to inconsistent coding.

Configuration Settings

Configuration ItemRecommended ValueRationale for this Value
maxContext4096 tokensAccommodates the length of most compound structure descriptions and target information
timeout600 secondsHandles potential delays from complex structure queries or multi-source data aggregation
recall_top_kTop 5 entriesBalances retrieval efficiency with information completeness, ensuring key targets are recalled
threshold_score0.75Filters for highly relevant results, reducing interference from irrelevant information
max_retries3 timesAddresses temporary external API failures, improving system robustness
response_formatJSONFacilitates programmatic parsing and subsequent processing

Three Common Mistakes

  • The tool calling module does not trigger. This manifests as the model response lacking tool execution logs or results. The cause is often the model determining that the current input does not require tool assistance, or insufficient guidance for tool use in the prompt.
  • External API returns data in a mismatched format. This manifests as parsing failures or empty fields. The cause is the structure of the external data source (e.g., XML versus JSON) not matching the format expected by the tool, lacking necessary conversion logic.
  • Query results do not match expectations. This manifests as drug adverse event codes failing to match. The cause is differences in MedDRA versions or unstandardized query terms, leading to inaccurate retrieval.

How to Verify Correct Configuration

  • Simulate typical queries to check if the model correctly identifies and calls the pre-configured target discovery tools.
  • Review tool call logs to confirm that parameter passing and returned data structures match expectations.
  • For target affinity values, verify if the tool provides consistent or correctly converted results when given inputs in different units (nM, µM).
  • Use MedDRA codes for queries to verify if the tool accurately matches and recalls relevant adverse events.

Note: The values provided are common starting points. Measure them against your own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.